Neurofibroma medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
==Medical Therapy==
==Medical Therapy==
'''Chemotherapy'''
'''Chemotherapy'''
* Once a [[plexiform neurofibroma]] has undergone malignant transformation, [[chemotherapy]] can be used as treatment.<ref name=radio> Neurofibroma. Dr Bruno Di Muzio and Dr Maxime St-Amant et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/neurofibroma </ref>
* Once a [[plexiform neurofibroma]] has undergone [[malignant transformation]], [[chemotherapy]] can be used as treatment.<ref name=radio> Neurofibroma. Dr Bruno Di Muzio and Dr Maxime St-Amant et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/neurofibroma </ref>
   
   
'''Radiation'''
'''Radiation'''
* Radiation is generally not used as a treatment for plexiform neurofibromas because of concerns that this could actually promote malignant transformation. There has even been a documented case of a Schwannoma being induced from a neurofibroma due to radiation therapy.<ref name=" pmid8998885">{{cite journal |author=Isler MH, Fogaça MF, Mankin HJ. |title=Radiation induced malignant schwannoma arising in a neurofibroma |journal=Clinical Orthopaedics and Related Research  |issue=325 |pages=251–5 |year=1996 |pmid=8998885|doi=10.1097/00003086-199604000-00031 |volume=325}}</ref>
* [[Radiation]] is generally not used as a treatment for [[plexiform neurofibroma]]s because of concerns that this could actually promote malignant transformation. There has even been a documented case of a [[schwannoma]] being induced from a neurofibroma due to radiation therapy.<ref name=" pmid8998885">{{cite journal |author=Isler MH, Fogaça MF, Mankin HJ. |title=Radiation induced malignant schwannoma arising in a neurofibroma |journal=Clinical Orthopaedics and Related Research  |issue=325 |pages=251–5 |year=1996 |pmid=8998885|doi=10.1097/00003086-199604000-00031 |volume=325}}</ref>


'''Medications'''
'''Medications'''
* [[ACE inhibitor]]s have been proposed as a novel treatment of neurofibromas.<ref name=" pmid18157575">{{cite journal |author=Namazi H. |title=ACE inhibitors: a novel treatment for neurofibroma |journal=Clinical Orthopaedics and Related Research |volume=15 |issue=5 |pages=1538–9 |year=2008 |pmid=18157575|doi=10.1245/s10434-007-9737-5}}</ref>   
* [[ACE inhibitor]]s have been proposed as a novel treatment of neurofibromas.<ref name=" pmid18157575">{{cite journal |author=Namazi H. |title=ACE inhibitors: a novel treatment for neurofibroma |journal=Clinical Orthopaedics and Related Research |volume=15 |issue=5 |pages=1538–9 |year=2008 |pmid=18157575|doi=10.1245/s10434-007-9737-5}}</ref>   
* ACE inhibitors are currently used to treat hypertension and congestive heart failure, to avert remodeling and reinfarction after myocardial infarction, and to ameliorate diabetic nephropathy and other renal diseases.  
* ACE inhibitors are currently used to treat [[hypertension]] and [[congestive heart failure]], to avert remodeling and reinfarction after [[myocardial infarction]], and to ameliorate [[diabetic nephropathy]] and other renal diseases.  
* ACE inhibitors work by indirectly down regulating [[TGF beta|TGF-beta]], which is a growth factor that has been shown to influence the development of tumors.<ref name=" pmid18157575">{{cite journal |author=Namazi H. |title=ACE inhibitors: a novel treatment for neurofibroma |journal=Clinical Orthopaedics and Related Research |volume=15 |issue=5 |pages=1538–9 |year=2008 |pmid=18157575|doi=10.1245/s10434-007-9737-5}}</ref>
* ACE inhibitors work by indirectly down regulating [[TGF beta|TGF-beta]], which is a growth factor that has been shown to influence the development of [[tumors]].<ref name=" pmid18157575">{{cite journal |author=Namazi H. |title=ACE inhibitors: a novel treatment for neurofibroma |journal=Clinical Orthopaedics and Related Research |volume=15 |issue=5 |pages=1538–9 |year=2008 |pmid=18157575|doi=10.1245/s10434-007-9737-5}}</ref>


==References==
==References==

Revision as of 14:29, 17 November 2015

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma medical therapy

CDC on Neurofibroma medical therapy

Neurofibroma medical therapy in the news

Blogs on Neurofibroma medical therapy

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

The predominant therapy for neurofibroma is surgical resection. Adjunctive chemotherapy and medications may be required.

Medical Therapy

Chemotherapy

Radiation

  • Radiation is generally not used as a treatment for plexiform neurofibromas because of concerns that this could actually promote malignant transformation. There has even been a documented case of a schwannoma being induced from a neurofibroma due to radiation therapy.[2]

Medications

References

  1. Neurofibroma. Dr Bruno Di Muzio and Dr Maxime St-Amant et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/neurofibroma
  2. Isler MH, Fogaça MF, Mankin HJ. (1996). "Radiation induced malignant schwannoma arising in a neurofibroma". Clinical Orthopaedics and Related Research. 325 (325): 251–5. doi:10.1097/00003086-199604000-00031. PMID 8998885.
  3. 3.0 3.1 Namazi H. (2008). "ACE inhibitors: a novel treatment for neurofibroma". Clinical Orthopaedics and Related Research. 15 (5): 1538–9. doi:10.1245/s10434-007-9737-5. PMID 18157575.


Template:WikiDoc Sources